Zuber Lawler is deeply committed to advancing the fast-developing field of human longevity, encompassing extended lifespan, enhanced healthspan, and sustained vitality. Our team has advised clients across the full spectrum of the industry, from iconic Fortune 500 pharmaceutical and biotech companies to pioneering start-ups developing disruptive longevity solutions.
What sets our practice apart is the convergence of sophisticated legal acumen with deep scientific and technical fluency. Many of our attorneys hold degrees in biosciences, engineering, and related fields, enabling us to understand the science behind breakthroughs in genomics, regenerative medicine, cellular therapies, and AI-driven drug discovery. We also bring capacity in complementary technologies, including artificial intelligence, robotics, advanced manufacturing, and nanotechnology, that increasingly intersect with longevity innovations.
Our culture prioritizes forward-looking problem-solving. The Zuber Lawler team includes creative dealmakers, scientists and engineers, visionary futurists, and founders with long-standing, personal commitment to helping our clients help people around the world stay younger longer. This diversity of perspectives allows us to anticipate industry shifts, craft innovative transaction structures, and navigate complex cross-border challenges.
